Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
June 2, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply
Nathalie E Blachere, Ezgi Hacisuleyman, Robert B Darnell
Cancer Immunity
|
May 16, 2003
Immunization against a dominant tumor antigen abrogates immunogenicity of the tumor
Amira Makki, Gunnar Weidt, Nathalie E Blachere, et al.
The Journal of Surgical Research
|
February 14, 2002
Xenogeneic DNA immunization in melanoma models for minimal residual disease
William G Hawkins, Jason S Gold, Nathalie E Blachere, et al.
Oncogene
|
May 11, 2004
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor
Teresa Ramirez-Montagut, Nathalie E Blachere, Elena V Sviderskaya, et al.
Elife
|
February 8, 2013
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo
Dana E Orange, Nathalie E Blachere, John Fak, et al.
Cancer Immunity
|
March 5, 2005
Antigens recognized by autologous antibodies of patients with soft tissue sarcoma
Neil H Segal, Nathalie E Blachere, Ho Yin A Shiu, et al.
Seminars in Cancer Biology
|
April 3, 2002
Strategies to overcome immune ignorance and tolerance
Miguel-Angel Perales, Nathalie E Blachere, Manuel E Engelhorn, et al.
Vaccine
|
March 5, 2003
The role of lipopolysaccharide in T-cell responses following DNA vaccination
William G Hawkins, Jiri Trcka, Neil Segal, et al.
Elife
|
June 1, 2018
ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
Michael J Moore, Nathalie E Blachere, John J Fak, et al.
Cancer Immunity
|
February 3, 2005
Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics
Neil H Segal, Nathalie E Blachere, Jose A Guevara-Patiño, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
June 2, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply
Nathalie E Blachere, Ezgi Hacisuleyman, Robert B Darnell
Cancer Immunity
|
May 16, 2003
Immunization against a dominant tumor antigen abrogates immunogenicity of the tumor
Amira Makki, Gunnar Weidt, Nathalie E Blachere, et al.
The Journal of Surgical Research
|
February 14, 2002
Xenogeneic DNA immunization in melanoma models for minimal residual disease
William G Hawkins, Jason S Gold, Nathalie E Blachere, et al.
Oncogene
|
May 11, 2004
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor
Teresa Ramirez-Montagut, Nathalie E Blachere, Elena V Sviderskaya, et al.
Elife
|
February 8, 2013
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo
Dana E Orange, Nathalie E Blachere, John Fak, et al.
Cancer Immunity
|
March 5, 2005
Antigens recognized by autologous antibodies of patients with soft tissue sarcoma
Neil H Segal, Nathalie E Blachere, Ho Yin A Shiu, et al.
Seminars in Cancer Biology
|
April 3, 2002
Strategies to overcome immune ignorance and tolerance
Miguel-Angel Perales, Nathalie E Blachere, Manuel E Engelhorn, et al.
Vaccine
|
March 5, 2003
The role of lipopolysaccharide in T-cell responses following DNA vaccination
William G Hawkins, Jiri Trcka, Neil Segal, et al.
Elife
|
June 1, 2018
ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
Michael J Moore, Nathalie E Blachere, John J Fak, et al.
Cancer Immunity
|
February 3, 2005
Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics
Neil H Segal, Nathalie E Blachere, Jose A Guevara-Patiño, et al.
Page
of 2